SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-19-046550
Filing Date
2019-08-19
Accepted
2019-08-19 18:41:34
Documents
2
Period of Report
2019-08-08

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 7982
2 EX-24.1 ex-24d1.htm EX-24.1 9922
  Complete submission text file 0001104659-19-046550.txt   19251
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Issuer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address (203) 404-0410
Stock Elyse (Reporting) CIK: 0001785732 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38080 | Film No.: 191037579